Berlin, Germany

Philipp Westphal


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Philipp Westphal: A Pioneer in Cardiovascular Treatment

Introduction: Philipp Westphal, an accomplished inventor based in Berlin, Germany, has made significant contributions to the field of cardiovascular medicine. With a keen focus on metabolic health, he has developed innovative compounds that aim to improve treatment options for cardiac diseases. His groundbreaking work has earned him recognition within the scientific community and a patent that showcases his dedication to improving health outcomes.

Latest Patents: Westphal holds a notable patent titled "Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease." This invention encompasses compounds represented by general formula (I), which are designed to be metabolically robust analogs of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs). The implications of this patent include compositions containing these compounds and their potential therapeutic uses for the treatment or prevention of cardiovascular diseases.

Career Highlights: Philipp Westphal has had a distinguished career, working at esteemed organizations including the Max Delbrück Center for Molecular Medicine and the University of Texas System. His work in these institutions has significantly contributed to advancements in the understanding of cardiovascular health and the development of innovative treatment strategies.

Collaborations: Throughout his career, Westphal has collaborated with talented individuals such as Robert Fischer and Anne Konkel. These partnerships have fostered a rich exchange of ideas and expertise, further enhancing the depth and impact of his research.

Conclusion: Philipp Westphal's innovative spirit and dedication to improving cardiac health through his patent on metabolic analogs of CYP-eicosanoids highlight the importance of research and invention in medicine. As he continues his work, his contributions stand to make a lasting impact on the treatment and prevention of cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…